![]() |
市場調査レポート
商品コード
1439330
尿管鏡 - 世界市場の考察、競合情勢、市場予測(2030年)Ureteroscope - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
||||||
カスタマイズ可能
適宜更新あり
|
尿管鏡 - 世界市場の考察、競合情勢、市場予測(2030年) |
出版日: 2024年02月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の尿管鏡の市場規模は、2023年に9億米ドル、2030年までに12億4,000万米ドルに達し、2024年~2030年の予測期間にCAGRで5.49%の成長が見込まれます。尿管鏡の需要の増加は、腎結石発生の危険因子である肥満の負担増に伴う尿路結石または腎結石の有病率の増加によるものと考えられます。また、座りがちなライフスタイル、製品設計の革新、新製品の発売などが市場成長の要因となっています。
尿管鏡の市場力学
尿管鏡は、世界中で尿路結石の有病率が上昇していることから、近年勢いを増しています。European Association of Urology(2019)によると、尿路結石の有病率は1%から20%とさまざまであり、カナダ、スウェーデン、米国のような生活水準の高い国では、腎結石の有病率が著しく高い(10%超)です。
さらに、アルコールの過剰摂取や水分摂取の減少など、座りがちなライフスタイルの増加も腎結石の発生につながる可能性があります。さらに、食生活の乱れや運動不足などの座りがちなライフスタイルが原因で、腎結石発生のハイリスク因子である肥満の負担が人々の間で増加していることも、尿管鏡市場の成長に寄与する可能性があります。世界保健機関(WHO)(2022)のデータによると、2016年の世界の肥満人口は約6億5,000万人でした。また、さまざまな研究(2020年にNCBIで発表されたPoore W.らによる「Obesity and Its Impact on Kidney Stone Formation」がその1つ)によると、肥満の人々は尿酸結石やシュウ酸カルシウム結石をより多く発症しています。
したがって、前述の要因が世界の尿管鏡市場の成長を増大させると予測されます。
しかし、医療現場において尿管鏡を使用する熟練労働者が限られていることや、尿管鏡のコストが高いことなどが、尿管鏡市場の成長にとって課題となることが予測されます。
尿管鏡市場のセグメント分析
尿管鏡製品セグメントでは、予測期間に軟性尿管鏡が最大の市場シェアを占めると予測されています。これは、さまざまな腎臓結石や尿管結石の治療に軟性尿管鏡が広く使用されているためです。また、軟性尿管鏡は半硬性尿管鏡と比較すると最新世代の装置であるため、患者に与える痛みや不快感が少なく、傷害の可能性も低いです。半硬性尿管鏡に対する軟性尿管鏡の利点は、患者の需要を軟性尿管鏡にシフトさせ、軟性尿管鏡市場を拡大させます。さらに、病院における軟性尿管鏡検査の増加も軟性尿管鏡市場の促進要因です。例えば、軟性尿管鏡はほぼすべての病院で、泌尿器科医が尿路結石のよりよい管理に向け、レーザー結石破砕術とともに高い成功率と低い合併症率で広く使用されています。さらに、逆行性軟性尿管鏡検査(RFU)は尿路上皮がんの診断に高い感度を有しています。
したがって、上記の要因が軟性尿管鏡市場を牽引すると予測されます。
北米が尿管鏡市場全体を独占すると予測されます
すべての地域の中で、北米が尿管鏡市場全体を独占すると予測されています。この優位性は、この地域の有利な償還シナリオ、先進の医療インフラ、上路結石疾患の外科的および内科的管理に向けた詳細なガイドラインによるもので、尿管鏡市場を押し上げると予測されています。
さらに、米国における上部尿路上皮がん(UTUC)の症例の増加も、尿管鏡の使用増加の理由となっています。例えば、米国疾病予防管理センター(CDC)(2020)のデータによると、米国では約1万7,500人の女性と5万6,000人の男性が膀胱がんに苦しんでいます。また、Canadian cancer society(2020)のデータによると、2020年に約1万2,200人のカナダ人が膀胱がんを患っていました。
加えて、この地域における新製品の発売は、地域の尿管鏡市場を後押しする可能性が高いです。例えば2019年、Dornier Medtechは、米国で新しいAXISシングルユースデジタル軟性尿管鏡を発売し、すぐに入手可能であることを発表しました。したがって、これらの要因が予測期間に尿管鏡市場に寄与する見込みです。
当レポートでは、世界の尿管鏡市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。
Ureteroscope Market By Product Type (Flexible Ureteroscope [Digital Ureteroscope and Fiber Optic Ureteroscope], Semi-Rigid Ureteroscope), By Channel Type (Dual Channel and Single Channel), By Usability (Single-Use and Reusable), By Application (Urolithiasis, Urothelium Cancer, Urinary Strictures), By End-User (Hospitals, Ambulatory Surgical Centers, and Others), By Geography, is expected to grow at a constant CAGR forecast till 2030 due to the growing prevalence of urolithiasis among the population and technological advancement in the product portfolio.
The global ureteroscope market was valued at USD 0.90 billion in 2023, growing at a CAGR of 5.49% during the forecast period from 2024 to 2030, to reach USD 1.24 billion by 2030. The rise in demand for ureteroscope can be due to the growing prevalence of urolithiasis or nephrolithiasis accompanied by the rising burden of obesity which is a risk factor for development of kidney stones. In addition, sedentary lifestyle, innovation in product design, and new product launches among others are the factors responsible for the global market growth of ureteroscope.
Ureteroscope Market Dynamics:
Ureteroscope is gaining momentum in recent years owing to the rising prevalence of urolithiasis across the globe. According to the European Association of Urology 2019, the prevalence rates for urinary stones vary from 1% to 20%, and in the countries with a high standard of life such as Canada, Sweden, or the US, renal stones prevalence is significantly high (>10%).
Moreover, a rise in sedentary lifestyle such as excessive consumption of alcohol, less consumption of water could also lead to the development of kidney stones. In addition, the growing burden of obesity among the population, a high-risk factor for the development of renal calculi, due to sedentary lifestyles such as poor dietary habits and lack of physical activities could also contribute to the ureteroscope market growth. As per the World Health Organization (WHO) 2022 data, there was around 650 million obese population worldwide in the year 2016. Also, according to various studies (one of them being "Obesity and Its Impact on Kidney Stone Formation" by Poore W. et al., published in the NCBI in the year 2020) obese people develop more uric acid stones and calcium oxalate stones.
Thus, the aforementioned factors are anticipated to augment the global ureteroscope market growth.
However, certain factors such as the limited availability of a skilled workforce to utilise the device in medical setup and the high cost of ureteroscope devices are expected to pose a challenge to the ureteroscope market growth.
Ureteroscope Market Segment Analysis:
Ureteroscope Market Product Type (Flexible Ureteroscope [Digital Ureteroscope and Fiber Optic Ureteroscope], Semi-Rigid Ureteroscope), By Channel Type (Dual Channel and Single Channel), By Usability (Single-Use and Reusable), By Application (Urolithiasis, Ureter Transitional Cell Cancer, Urinary Strictures), By End User (Hospitals, Ambulatory Surgical Centers and Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the Ureteroscope product segment, the flexible ureteroscope is anticipated to hold the largest market share during the forecasted period. This is due to the wide use of the flexible ureteroscope for the treatment of various kidney and ureter stones. Also, flexible ureteroscopy is a latest generation of device when compared to semi rigid ureteroscopy and thus they causes minimum pain and discomfort to the patient with low chances of injury. The advantages of flexible ureteroscopy over semi-rigid ureteroscopy will shift the demand of patients towards flexible ureteroscopy thereby increasing the market for flexible ureteroscope. Moreover, increase in flexible ureteroscopy in hospitals is also a factor driving the market for flexible ureteroscope. For instance, flexible ureteroscope are widely used along with laser lithotripsy in nearly all hospitals by the urologists for better management of urolithiasis with high success rate and low complication rate. Moreover, retrograde flexible ureteroscopy (RFU) has high sensitivity for the diagnosis of urinary tract urothelial carcinomas.
Thus, the above-mentioned factors are expected to drive the flexible ureteroscope market.
North America is expected to dominate the overall Ureteroscope Market:
Among all the regions, North America is expected to dominate the overall ureteroscope market. This domination is owing to the favourable reimbursement scenario, advanced healthcare infrastructure, and well-versed guidelines for the surgical and medical management of the upper tract stone disease in the region is projected to boost the ureteroscope market.
Further, in the United States the rising cases of upper tract urothelial carcinoma (UTUC), is also the reason for increase in usage of ureteroscope. For instance, as per the Centers for Disease Control and Prevention (CDC) 2020 data, approximately 17,500 women and 56,000 men suffer from bladder cancer in the US. Moreover, according to the Canadian cancer society 2020 data, there were around 12,200 Canadians suffered from bladder cancer in the year 2020.
In addition, the launch of new products in the region is likely to propel the market for ureteroscope in the region. For instance, in 2019, Dornier Medtech launched and announced the immediate availability of its new AXIS single-use digital flexible ureteroscope in the US. Thus, these factors are projected to contribute to the ureteroscope market during the forecasted period.
Additionally, the Asia-pacific region has future potential for the ureteroscope market. This is because of the rising number of kidney and bladder cancer in the region. Also, the growing cases of urolithiasis are factors expected to promote the growth of ureteroscope in the region. For instance, as per the GLOBOCAN 2022 data, there were approximately 21,096 and 16,861 cases of bladder and kidney respectively in India in the year 2020. Moreover, improving healthcare infrastructure, growing disposable income in the region could also boost the ureteroscope market.
Ureteroscope Market Key Players:
Some of the key market players operating in the Ureteroscope market include Olympus, Stryker, Boston Scientific Corporation, Richard Wolf GmbH, KARL STORZ, ELMED Medical Systems, PENTAX Medical, OPCOM, Dornier Medtech, Maxer Endoscopy GmbH, Vimex Sp. z o. o., AED.MD, NeoScope Inc., Advin Health Care, OTU Medical., Clarion Medical Technologies., Zhuhai Mindhao Medical Technology Co., Ltd., Innovex Medical Co., Ltd., Biorad Medisys Pvt Ltd., Shanghai SeeGen Photoelectric Technology Co., Ltd., and others.
Recent Developmental Activities in the Ureteroscope Market:
In August 2020, Olympus Winter & Ibe GmbH received the US FDA approval for OES Elite Ureteroscopes and Accessories under regulatory class II for endoscopic observation and therapy in the ureters, urethra, and urinary bladder.
Key Takeaways from the Ureteroscope Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyse suitable indicators, our experts are closely watching the Ureteroscope market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the Global Ureteroscope Market.
Various opportunities available for the other competitor in the Ureteroscope Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Ureteroscope market growth in the coming future?
Target Audience Who Can Be Benefited from the Ureteroscope Market Report Study
Ureteroscope providers
Research organizations and consulting companies
Ureteroscope-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in Ureteroscope
Various End-users who want to know more about the Ureteroscope Market and latest technological developments in the Ureteroscope market.
Frequently Asked Questions for the Ureteroscope Market:
Ureteroscope is a small flexible telescope that is inserted into the bladder and ureter to diagnose and treat a variety of problems associated with the urinary tract.
The global ureteroscope market was valued at USD 0.90 billion in 2023, growing at a CAGR of 5.49% during the forecast period from 2024 to 2030, to reach USD 1.24 billion by 2030.
The major factors driving the demand for Ureteroscope are the rising cases of urolithiasis, increase in demand for minimally invasive procedures for kidney stone management, rising sedentary lifestyle, among others. In addition, new product launch and technological advancement in the ureteroscope product portfolio is also expected to augment the market.
Some of the key market players operating in the Ureteroscope market include Olympus, Stryker, Boston Scientific Corporation, Richard Wolf GmbH, KARL STORZ, ELMED Medical Systems, PENTAX Medical, OPCOM, Dornier Medtech, Maxer Endoscopy GmbH, Vimex Sp. z o. o., AED.MD, NeoScope Inc., Advin Health Care, OTU Medical., Clarion Medical Technologies., Zhuhai Mindhao Medical Technology Co., Ltd., Innovex Medical Co., Ltd., Biorad Medisys Pvt Ltd., Shanghai SeeGen Photoelectric Technology Co., Ltd., and others.
Among all the regions, North America is expected to dominate the overall ureteroscope market during the forecasted period, 2024-2030. This domination is owing to the favorable reimbursement scenario, advanced healthcare infrastructure, and well-versed guidelines for the surgical and medical management of the upper tract stone disease in the region is projected to boost the ureteroscope market.